Notice
Shipping is $36.95 + a $6 surcharge for ice. Your order will ship via Express 1-2 day mail and will be packed in an insulated box with ice packs. Items that are required to ship this method will be listed in the item description. Orders placed after 2:00 PM EST (11:pp AM PST) may not end up being able to ship out the same day.
Restrictions: All foreign orders are ineligible. Free shipping is ineligible.
Note: Vaccine orders are only shipped out on Mon-Wed. due to Express service only being able to deliver during weekdays. We cannot be responsible for vaccine or other refrigerated orders that are delayed because no one is present at the time it is delivered.
Description
- Features & Benefits
- A quality core vaccine that protects against feline rhinotracheitis, feline panleukopenia virus (FPV), and feline calicivirus (FCV), in addition to providing extenseive 2-year coverage for FeLV.
- Nobivac Feline 1-HCP has been shown block the replication of canine parvovirus (CPV) in cats.1
- Evidence shows that CPV-2a, CPV-2b, and CPV-2c isolates can replicate in cats, producing clinical signs of feline panleukopenia.2-4
- The only feline leukemia vaccine labeled to prevent persistent viremia for 2 years after vaccination.5
- Superior Efficacy demonstrated vs. multiple FeLV vaccines.6-7
- The ONLY USDA-licensed 2-year Duration of Immunity (DOI) FeLV vaccine (Ideal for adherence to AAFP guidelines)1,5,8
- The oNLY vaccine to demonstrate efficacy over the long-term in a co-mingling study mimicking real life conditions.1
- Proven safety profile-99% reaction-free in ongoing surveillance involving millions of doses.1
- The optimal choice for both indoor and outdoor cats of all ages and for all cats under 1 year of age
- Indications
- Approved for the vaccination of healthy cats as an aid in the prevention of disease caused by feline rhinotracheitis, calici, and panleukopenia viruses
- Approved as an aid in the prevention of lymphoid tumors caused by, and diseases associated with feline leukemia virus (FeLV) infection
- Vaccination with this product prevents persistent viremia in cats exposed to virulent FeLV
- Recommended for use in healthy cats 9 weeks of age or older
Nobivac is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.
Useful Information
-
Safety Information
- 98.8% reaction-free in field safety studies
- 99.99% reaction-free in ongoing surveillance involving millions of doses.1
- Study showed no signs of inflammation or adjuvant at Day 21 after subcutaneous vaccination.1
- Two-year DOI means fewer vaccinations
PRECAUTIONS:
WARNINGS: